Biotech Stocks

US-listed biological-products companies: therapies derived from biological processes, distinct from small-molecule pharmaceutical manufacturers.

71 companies

Companies

Combined revenue

$96.44B

Median net margin

6.0%

Median P/E

18.4×

Company	Revenue	Net margin	P/E	Market cap
AMGEN INC (AMGN)	$36.75B	21.0%	25.3×	$196.12B
GILEAD SCIENCES, INC. (GILD)	$29.44B	28.9%	17.7×	$161.19B
BIOGEN INC. (BIIB)	$9.89B	13.1%	22.5×	$30.86B
NEUROCRINE BIOSCIENCES INC (NBIX)	$2.86B	16.7%	26.8×	$17.30B
EXELIXIS, INC. (EXEL)	$2.32B	33.7%	18.6×	$14.02B
QIAGEN N.V. (QGEN)	$2.09B	20.3%	19.4×	$8.66B
Moderna, Inc. (MRNA)	$1.94B	—	—	$26.59B
HALOZYME THERAPEUTICS, INC. (HALO)	$1.40B	22.7%	27.6×	$9.33B
BIO-TECHNE Corp (TECH)	$1.22B	6.0%	101.9×	$11.11B
NOVAVAX INC (NVAX)	$1.12B	39.2%	3.6×	$1.55B
BIOCRYST PHARMACEUTICALS INC (BCRX)	$874.8M	30.2%	8.6×	$2.66B
REPLIGEN CORP (RGEN)	$738.3M	6.6%	158.5×	$8.14B
ADMA BIOLOGICS, INC. (ADMA)	$510.2M	28.8%	13.6×	$2.10B
Tarsus Pharmaceuticals, Inc. (TARS)	$451.4M	-14.6%	—	$2.54B
Immunocore Holdings plc (IMCR)	$400.0M	-8.9%	—	$1.63B
Krystal Biotech, Inc. (KRYS)	$389.1M	52.6%	49.0×	$10.78B
Twist Bioscience Corp (TWST)	$376.6M	-20.6%	—	$5.64B
Adaptive Biotechnologies Corp (ADPT)	$277.0M	-21.5%	—	$3.37B
Vericel Corp (VCEL)	$276.3M	6.0%	110.4×	$2.43B
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)	$263.5M	—	—	$1.89B
Vaxart, Inc. (VXRT)	$237.3M	0.0%	3.3×	$129.3M
Adaptimmune Therapeutics PLC (ADAPY)	$178.0M	-39.8%	—	$8.7M
REGENXBIO Inc. (RGNX)	$170.4M	—	—	$776.5M
Ginkgo Bioworks Holdings, Inc. (DNA)	$170.2M	-0.2%	—	$593.8M
Beam Therapeutics Inc. (BEAM)	$139.7M	-57.2%	—	$3.36B
Monte Rosa Therapeutics, Inc. (GLUE)	$123.7M	-31.2%	—	$2.06B
Atara Biotherapeutics, Inc. (ATRA)	$120.8M	27.1%	3.1×	$72.4M
AGENUS INC (AGEN)	$114.2M	-2.7%	—	$211.5M
ImmunityBio, Inc. (IBRX)	$113.3M	—	—	$9.17B
Century Therapeutics, Inc. (IPSC)	$109.2M	-8.8%	—	$416.6M
SUTRO BIOPHARMA, INC. (STRO)	$102.5M	—	—	$532.4M
4D Molecular Therapeutics, Inc. (FDMT)	$85.2M	—	—	$670.2M
MeiraGTx Holdings plc (MGTX)	$81.4M	—	—	$1.36B
Autolus Therapeutics plc (AUTL)	$75.4M	—	—	$385.9M
RECURSION PHARMACEUTICALS, INC. (RXRX)	$74.7M	—	—	$2.04B
COMPUGEN LTD (CGEN)	$72.8M	48.6%	6.1×	$217.5M
Black Diamond Therapeutics, Inc. (BDTX)	$70.0M	—	4.8×	$106.6M
Vir Biotechnology, Inc. (VIR)	$68.6M	—	—	$1.73B
CHAMPIONS ONCOLOGY, INC. (CSBR)	$56.9M	8.3%	18.4×	$84.2M
Invivyd, Inc. (IVVD)	$53.4M	-98.2%	—	$244.5M
Protalix BioTherapeutics, Inc. (PLX)	$52.7M	-12.5%	—	$190.1M
FENNEC PHARMACEUTICALS INC. (FENC)	$44.6M	—	—	$356.1M
Coherus Oncology, Inc. (CHRS)	$42.2M	—	1.2×	$254.5M
Editas Medicine, Inc. (EDIT)	$40.5M	—	—	$575.5M
Voyager Therapeutics, Inc. (VYGR)	$40.4M	—	—	$195.8M
SANGAMO THERAPEUTICS, INC (SGMOQ)	$39.6M	—	—	—
Kymera Therapeutics, Inc. (KYMR)	$39.2M	—	—	$9.81B
C4 Therapeutics, Inc. (CCCC)	$35.9M	—	—	$463.3M
X4 Pharmaceuticals, Inc (XFOR)	$35.1M	—	—	$373.5M
PRECISION BIOSCIENCES INC (DTIL)	$34.3M	—	—	$238.7M
Scilex Holding Co (SCLX)	$30.3M	—	—	$64.2M
Metagenomi Therapeutics, Inc. (MGX)	$25.2M	—	—	$48.6M
Alector, Inc. (ALEC)	$21.0M	—	—	$154.3M
LENZ Therapeutics, Inc. (LENZ)	$19.1M	—	—	$192.2M
Pelthos Therapeutics Inc. (PTHS)	$16.8M	—	—	$97.3M
Relay Therapeutics, Inc. (RLAY)	$15.4M	—	—	$4.28B
Lineage Cell Therapeutics, Inc. (LCTX)	$13.6M	—	—	$321.6M
ELUTIA INC. (ELUT)	$12.3M	—	1.1×	$42.0M
Caribou Biosciences, Inc. (CRBU)	$11.2M	—	—	$192.4M
TScan Therapeutics, Inc. (TCRX)	$10.3M	—	—	$82.3M
Alpha Cognition Inc. (ACOG)	$10.2M	—	—	$185.5M
Taysha Gene Therapies, Inc. (TSHA)	$9.8M	—	—	$1.89B
CURIS INC (CRIS)	$9.4M	-80.3%	—	$9.7M
FATE THERAPEUTICS INC (FATE)	$6.6M	—	—	$352.0M
DBV Technologies S.A. (DBVT)	$5.6M	—	—	$951.7M
CRISPR Therapeutics AG (CRSP)	$3.5M	—	—	$5.25B
Surrozen, Inc./DE (SRZN)	$3.5M	—	—	$272.8M
Artiva Biotherapeutics, Inc. (ARTV)	$0	—	—	$452.4M
Denali Therapeutics Inc. (DNLI)	$0	—	—	$4.08B
Revolution Medicines, Inc. (RVMD)	$0	—	—	$40.63B
Maze Therapeutics, Inc. (MAZE)	—	—	—	$1.82B

Other industries

Semiconductor Stocks Software Stocks Pharmaceutical Stocks REIT Stocks Bank Stocks Oil and Gas Stocks Insurance Stocks Medical Device Stocks Restaurant Stocks

Screen biotech stocks on fundamentals

Filter this industry by margin, growth and valuation, compare any two companies side by side, and ask their filings a question with cited answers.

Start free

Industry grouping is derived from each company’s SEC-assigned SIC code, which is self-reported and coarse: a company is placed by its primary declared line of business. Financial statements come from SEC EDGAR; valuation figures use market data. Informational only. Not investment advice.